Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119183312 | 11918331 | 2 | F | 2014 | 20160816 | 20160115 | 20160825 | EXP | US-ALEXION-A201600121 | ALEXION | 56.56 | YR | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119183312 | 11918331 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | T3-AE1225B01 | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||
| 119183312 | 11918331 | 2 | C | COUMADIN | WARFARIN SODIUM | 1 | Unknown | 3.5 MG, QD | 0 | 3.5 | MG | QD | |||||||
| 119183312 | 11918331 | 3 | C | COUMADIN | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 119183312 | 11918331 | 4 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 325 MG, QD | 0 | 325 | MG | QD | |||||||
| 119183312 | 11918331 | 5 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, PRN | 0 | 40 | MG | /yr | |||||||
| 119183312 | 11918331 | 6 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 119183312 | 11918331 | 7 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | 300-30 MG AS NEEDED | 0 | /yr | |||||||||
| 119183312 | 11918331 | 8 | C | FOLVITE /00024201/ | 2 | Oral | 1 MG, QD | 0 | 1 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119183312 | 11918331 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 119183312 | 11918331 | 2 | Thrombosis |
| 119183312 | 11918331 | 3 | Cerebral venous thrombosis |
| 119183312 | 11918331 | 4 | Product used for unknown indication |
| 119183312 | 11918331 | 5 | Product used for unknown indication |
| 119183312 | 11918331 | 6 | Product used for unknown indication |
| 119183312 | 11918331 | 7 | Pain |
| 119183312 | 11918331 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119183312 | 11918331 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119183312 | 11918331 | Arthritis | |
| 119183312 | 11918331 | Fatigue | |
| 119183312 | 11918331 | Headache | |
| 119183312 | 11918331 | Hepatitis B | |
| 119183312 | 11918331 | Intracranial venous sinus thrombosis | |
| 119183312 | 11918331 | Nausea | |
| 119183312 | 11918331 | Oral herpes | |
| 119183312 | 11918331 | Pain in extremity | |
| 119183312 | 11918331 | Portal vein thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |